Using animal models of CVB3-induced chronic myocarditis and DCM, studies have revealed that Th22/IL-22 also has a protective role in chronic viral myocarditis and that IL-22 can inhibit cardiac fibrosis [114]. The gene discussed is IL22; the disease is fibrosis.